Research for Amyloid PET-MRI

Amyloid PET-MRI - Amyloid PET-MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040338

Enrollment

160

Registered

2020-06-01

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer, Alzheimer&#39

Interventions

PET/MRI scan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers, Alzheimer's disease or mild cognitive impairment patients, Parkinson's disease who will undergo amyloid PET/CT.

Exclusion criteria

Exclusion criteria: 1. Other neurodegenerative disease, multiple brain infarction, normal pressure hydrocephalus, brain tumor, epilepsy, subdural hematoma, multiple sclerosis, and brain contusion. 2. Specific abnormal findings on brain MRI. 3. drug induced parkinsonism 4. SWEDD 5. Metalic implants 6. Allergy to 123I-FP-CIT 7. Depression, schizophrenia 8. Alcohol or drug addicts 9. Psychological disorder 10. Severe systemic disease 11. Infection, metabolic disorders 12. Those who are hospitalized in nursing homes. 13. Those who participated in other clinical researches. 14. Those who will be scheduled to participate in other clinical researches. 15. Other reasons considered by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Standardized uptake value at PET/CT and PET/MRI	—

Countries

Japan

Contacts

Public ContactYasutaka Fushimi

Kyoto University Graduate School of Medicine Department of Diagnostic Imaging and Nuclear Medicine

diag_rad@kuhp.kyoto-u.ac.jp075-751-3760

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026